CohBar to Announce 2018 Fourth Quarter Financial Results and Host Conference Call on March 18, 2019
MENLO PARK, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the company will release its …